SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001178913-14-002958
Filing Date
2014-09-17
Accepted
2014-09-17 13:34:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A zk1415553.htm SC 13D/A 36967
  Complete submission text file 0001178913-14-002958.txt   38663
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50118 | Film No.: 141107393
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MOSHE AVIV TOWER 7 ZABOTINSKY STREET RAMAT GAN L3 52520
Business Address MOSHE AVIV TOWER 7 ZABOTINSKY STREET RAMAT GAN L3 52520 972-3-611-4514
Bio-Cell Ltd (Filed by) CIK: 0001385114 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A